Cercare Full Neuro Suite

FDA & CE | Neuro | CT & MRI | Amplifier Partner

Description of use

Perfusion application for Stroke, Oncology and Neurodegenerative diseases with fully automated and vendor agnostic processing. Perfusion maps are based on MR DSC and CT perfusion and includes SVD markers (CBV, CBF, MTT, TTP, Tmax) + Vascular Model perfusion markers (Delay, CTH, OEF, CMRO2, COV, Leakage).

We offer an automatic Stroke decision support solution with computation of MR/CT perfusion maps and delineations of infarct core and hypoperfused volumes by either thresholds method or Cercare Medical's patented AI algorithm.

In Oncology and Neurodegenerative diseases, the patented maps, such as Capillary Transit-time Heterogeneity (CTH) and Cerebral Metabolic Rate of Oxygen (CMRO2) can improve diagnosis and enable more precise monitoring of treatment effectiveness.

The application content is provided by the respective AI vendors.